1Zietse R,et al.Angiotensin converting enzyme inhibition dose not correct early defects in renal and vascular permeability in diabetes mellitus.Clin Sci(colch),1998,94:165.
2Sakamoto K,et al.Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist.Diabetologia,1995,38:536.
3Zhang PL,et al.Effects of an atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats.J Am Soc Nephrol,1994,4:1564.
4Hirata Y,et al.Participation of endogenous atrial natriuretic peptide in the rats of urinary protein excretion in experimental diabetes rats.Clin Sci(colch),1995,88:413.
5Shin SJ,et al.Increased atrial natriuretic peptide mRNA expression in the kidney of diabetic rats.Kindey Int,1997,51:1100.
6Zietse R,et al.Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.J Am Soc Nephrol,1995,5:2057.
7Jungmann E,et al.Human atrial natriuretic peptide in patients with type l diabetes mellitus:Is it related to the development of diabetic nephropathy? Clin Invest,1993,71:604.
